Results 11 to 20 of about 112,056 (332)

Structure-Activity Relationships of Dopamine Transporter Pharmacological Chaperones

open access: yesFrontiers in Cellular Neuroscience, 2022
Mutations in the dopamine transporter gene (SLC6A3) have been implicated in many human diseases. Among these is the infantile parkinsonism-dystonia known as Dopamine Transporter Deficiency Syndrome (DTDS).
Charles Sutton   +12 more
doaj   +1 more source

Restoration of the Dopamine Transporter through Cell Therapy Improves Dyskinesia in a Rat Model of Parkinson's Disease. [PDF]

open access: yesPLoS ONE, 2016
The dyskinesia of Parkinson's Disease is most likely due to excess levels of dopamine in the striatum. The mechanism may be due to aberrant synthesis but also, a deficiency or absence of the Dopamine Transporter.
D Tomas   +5 more
doaj   +1 more source

Is dopamine transporter gene effective on therapeutic response of methylphenidate in ADHD patients? [PDF]

open access: yesReviews in Clinical Medicine, 2015
Attention-deficit/hyperactivity disorder (ADHD) is the most common neuropsychiatric illness, which affects about 5% of children worldwide. An 80% genetic background is responsible for ADHD due to its appearance in familial relationships.
Fatemeh Moharrari, Soheila Barabadian
doaj   +3 more sources

Molecular Mechanism of Dopamine Transport by Human Dopamine Transporter [PDF]

open access: yesStructure, 2015
Dopamine transporters (DATs) control neurotransmitter dopamine (DA) homeostasis by reuptake of excess DA, assisted by sodium and chloride ions. The recent resolution of DAT structure (dDAT) from Drosophila permits us for the first time to directly view the sequence of events involved in DA reuptake in human DAT (hDAT) using homology modeling and full ...
Cheng, Mary Hongying, Bahar, Ivet
openaire   +2 more sources

Reduced Dopamine Transporter Availability and Neurocognitive Deficits in Male Patients with Alcohol Dependence. [PDF]

open access: yesPLoS ONE, 2015
Dopamine plays an important role in the development of alcohol dependence, cognitive dysfunction, and is regulated via dopamine transporter activity. Although dopamine transporter activity is critically involved in alcohol dependence, studies observing ...
Che-Hung Yen   +11 more
doaj   +1 more source

Altered Neurocircuitry in the Dopamine Transporter Knockout Mouse Brain [PDF]

open access: yes, 2010
The plasma membrane transporters for the monoamine neurotransmitters dopamine, serotonin, and norepinephrine modulate the dynamics of these monoamine neurotransmitters.
A Bonci   +133 more
core   +7 more sources

Substrates dissociate dopamine transporter oligomers [PDF]

open access: yesJournal of Neurochemistry, 2007
AbstractSubstrate‐induced endocytic trafficking of dopamine transporter (DAT) has been observed, but little is known about the regulation of DAT oligomerization by substrate. The present study investigates the effect on substrates on DAT oligomerization and explores a potential link with the presence of DAT at the cell surface in human embryonic kidney
Nianhang, Chen, Maarten E A, Reith
openaire   +2 more sources

Identification of novel target molecules of l-menthol

open access: yesHeliyon, 2021
The present study used a binding assay to identify novel target biomolecules of l-menthol ([−]-menthol) that promote mouse ambulation. Among 88 different ligands to specific biomolecules examined, 0.1 mM l-menthol inhibited the binding of 13 ligands with
Toyoshi Umezu
doaj   +1 more source

Prolyl Oligopeptidase Regulates Dopamine Transporter Phosphorylation in the Nigrostriatal Pathway of Mouse [PDF]

open access: yes, 2018
Alpha-synuclein is the main component of Lewy bodies, a histopathological finding of Parkinson's disease. Prolyl oligopeptidase (PREP) is a serine protease that binds to alpha-synuclein and accelerates its aggregation in vitro.
Julku, Ulrika H.   +7 more
core   +1 more source

Effect of methylphenidate treatment during adolescence on norepinephrine transporter function in orbitofrontal cortex in a rat model of attention deficit hyperactivity disorder [PDF]

open access: yes, 2015
Attention deficit hyperactivity disorder (ADHD) is associated with hypofunctional medial prefrontal cortex (mPFC) and orbitofrontal cortex (OFC). Methylphenidate (MPH) remediates ADHD, in part, by inhibiting the norepinephrine transporter (NET). MPH also
Dwoskin, Linda P.   +2 more
core   +4 more sources

Home - About - Disclaimer - Privacy